Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Badesch

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
American Journal of Respiratory and Critical Care Medicine|March 18, 2014
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell diseaseElizabeth S Klings, Roberto F Machado, Robyn J Barst, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
Blood|April 30, 2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F Machado, Robyn J Barst, Nancy A Yovetich, et al.
Plos One|July 3, 2014
Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomMark T Gladwin, Robyn J Barst, J Simon R Gibbs, et al.
Circulation|September 9, 2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United KingdomVandana Sachdev, Gregory J Kato, J Simon R Gibbs, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Haematologica|September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeMehdi Nouraie, Janet S Lee, Yingze Zhang, et al.
Circulation|April 1, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationVallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
American Journal of Respiratory and Critical Care Medicine|March 18, 2014
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell diseaseElizabeth S Klings, Roberto F Machado, Robyn J Barst, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
Blood|April 30, 2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F Machado, Robyn J Barst, Nancy A Yovetich, et al.
Plos One|July 3, 2014
Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomMark T Gladwin, Robyn J Barst, J Simon R Gibbs, et al.
Circulation|September 9, 2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United KingdomVandana Sachdev, Gregory J Kato, J Simon R Gibbs, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Haematologica|September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeMehdi Nouraie, Janet S Lee, Yingze Zhang, et al.
Circulation|April 1, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationVallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
Pageof 9